166 , 199207.e115 (2013)
Collectively, these recent contributions argue that future GSH-centric redox sensing and nanomedical approaches should (i) incorporate organelle targeting (especially mitochondria) to exploit subcellular redox heterogeneity, (ii) embed analyte-responsive activation into both therapeutic and imaging components, (iii) combine biochemical sensing with optical or thermal engineering for spatiotemporal control, and (iv) favor clinically translatable carriers (e.g., PLGA) for delivery
MastrorilliVScopaCSaraulliDCostanziMScardigliRRouaultJPet al
Yogi A, Callera GE, Antunes TT, Tostes RC, Touyz RM (2010) Vascular biology of magnesium and its transporters in hypertension
Whether youre considering NAD IV , NAD injections , or other forms of NAD intravenous therapy , the most important decision is how and where you receive treatment